ClinicalTrials.gg
CompletedNCT06332495RIDAECUBAUpdated Nov 9, 2026

Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and Caregivers

An observational study in Nurse-Patient Relations, sponsored by Nantes University Hospital. Completed at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Nantes University Hospital · Observational

How we know

Updated Nov 9, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
77
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Pain by Nantes University Hospital — none open to participants now, none under way, none of them phase 3. Pain · Nantes University Hospital.

Started
2024
the only one that year
Observational
5 of 12
none open now
Registered
12th of 12
by date

Among the 12 studies in Pain by Nantes University Hospital, this one is the only one that started in 2024, is one of 5 observational ones, and was the 12th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

None of the 12 studies in Pain by Nantes University Hospital is open now. The open studies under Pain, anywhere →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 12 studies in Pain by Nantes University Hospital as a file.
02

Study summary

The hypothesis is that the current bedpan is not adapted to the diversity of patients encountered. It is necessary to collect the opinions of patients themselves on the current pool in different departments in order to validate our hypothesis.

The objective is to evaluate pain in patients with reduced or very reduced mobility caused by the bedpan currently used in current practice through an observational study.

Read the detailed description

Patients with reduced or severely reduced mobility, over 18 years of age, bedridden and requiring the use of a bedpan, estimated hospitalization equal to or greater than 2 days on the ward.

03

Conditions studied

  • Nurse-Patient Relations

Browse trials for

Keywords

  • Bedpan
  • Discomfort
  • Alteration of Skin
  • Pain
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with reduced or severely reduced mobility, over 18 years of age, bedridden and requiring the use of a bedpan, estimated hospitalization equal to or greater than 2 days.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient of legal age (age ≥ 18 years).
  • Patient with reduced and very reduced mobility, bedridden requiring the use of a bedpan.
  • Estimated length of hospital stay on the ward ≥ 2 days.
  • Patient affiliated to a social security system.
  • Patient able to understand the protocol.
  • Patient having given oral non-opposition to participate.
  • Patient who has received the study information note.
  • Patient who had never participated in this study.

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive impairment preventing objective pain assessment or with neurological pathologies.
  • Patients under guardianship, curatorship or safeguard of justice.
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
77 participants (actual)
Patient registry
No

Groups and cohorts

  • Assessment of pain during pelvic positioning

    48-hour follow-up of patients included in the study, with data collected on two pelvis fittings per 24 hours of follow-up (one fitting = one installation and one removal).

    Other: Questioning the patient during hygiene care

Interventions

  • OtherQuestioning the patient during hygiene care

    The study examines how patients and caregivers feel when using the bedpan. Over the course of a day, collecting all this information would take just under 7 minutes. Over the duration of patient participation (2 days), we estimate that it would take a total of 15 minutes per patient to collect this information. The objectives are focused on pain and discomfort, and on the alteration of the (patient's) skin condition through objective observation of redness or stage I pressure sores by the caregiver.

06

What researchers measure

Primary outcomes

  1. Assessment of pain in a patient with reduced or very reduced mobility when using a bedpan.

    Pain will be assessed using a numerical pain scale (EN). The caregiver will ask the patient to rate his or her pain between 0 (no pain) and 10 (the most intense pain imaginable).

    Time frame: Four assessments in 48 hours

Secondary outcomes

  1. Assess the proportion of patients with a MCID of the pain felt by the patient in pre-installation > 1.3

    Time frame: 48 hours

  2. Assess the maximum pain felt by the patient pre/post and per/post use of the bedpan.

    Pain will be assessed using a numerical pain scale (EN). The caregiver will ask the patient to rate his or her pain between 0 (no pain) and 10 (the most intense pain imaginable).

    Time frame: 48 hours

  3. Assess patient discomfort on the bedpan

    discomfort will be defined by the addition of a cushion, rolled towel, treatment oil or the need for the bedpan to be repositioned

    Time frame: 48 hours

  4. Assess alteration of skin condition at the seat of the patient using the bedpan

    Appearance of stage I redness or pressure sores (redness that does not disappear) on the patient's seat, after using the bedpan

    Time frame: 48 hours

  5. Assess the caregiver's pain when handling the bedpan, placing the bedpan in position and removing the bedpan.

    Pain will be assessed using a numerical pain scale (EN). The caregiver will rate his or her pain between 0 (no pain) and 10 (the most intense pain imaginable).

    Time frame: 48 hours

  6. Assess the risk factors associated with the onset of pain when placing a bedpan.

    Time frame: 48 hours

  7. Assess the difficulty of positioning and removing the bedpan.

    Painfulness of placing and removing the bedpan, assessed by the caregiver using a Likert scale between 1 (easy) and 5 (impossible alone)

    Time frame: 48 hours

  8. Assess bedpan stability during use

    Stability will be evaluated by the tilting, or not, of the bedpan during use by the patient.

    Time frame: 48 hours

  9. Evaluate the effect of time spent on the bedpan on: pain, skin alteration and discomfort

    Time frame: 48 hours

07

Study locations

5 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Jul 2026, 23 months.

Of 505 non-industry observational studies under Pain, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 42. This study's 23 months is above that.

Counting every sponsor, half of 520 studies reached it within 18 months; a quarter within 8 and three quarters within 41.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Aug 2026 → Jul 2026 and completion Aug 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2024
First posted
Mar 27, 2024
StartActual
Aug 3, 2024
Primary completionActual
Jul 31, 2026was Aug 2026
CompletionActual
Jul 31, 2026was Aug 2026
Last update
Nov 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 9, 2026
Primary completion
Aug 1, 2026→Jul 31, 2026 (actual)
Nov 9, 2026
Study completion
Aug 3, 2026→Jul 31, 2026 (actual)
Nov 9, 2026
Enrollment
300 (estimated)→77 (actual)
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    Recruiting→Completed
    Primary completion Aug 1, 2026→Jul 31, 2026 (now actual)
    Study completion Aug 3, 2026→Jul 31, 2026 (now actual)
    Enrollment 300 (estimated)→77 (actual)
    + 4 other changes: verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06332495
Responsible party
Sponsor
First posted
Mar 27, 2024
Start date
Aug 3, 2024
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update
Nov 9, 2026

Study contacts

Pia SECHER
principal investigator · Nantes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion